Sex Hormones and Disease Flashcards
What are the benefits of postmenopausal HRT?
Improved bone density (decreased resorption); relief from flushes, fatigue, vaginal dryness by re-estb feedback control; reversal of atrophy of vulva, vagina, and urethra; improved sleep and pattern; reduced incidence of colorectal cancers; +/-reduced incidence of CHD and Alzheimer’s
What are the risks of postmenopausal HRT?
breast tenderness, nausea, fluid retention; increased risk of breast or uterine cancer; increased risk of thromboembolism and stroke
What is the mechanism of action of estrogen?
oestrogen crosses the plasma membrane; binds estrogen receptor (ER) in cytoplasm; receptors form homodimers which bind to specific oestrogen response elements (ERE) to activate gene transcription to mRNA
T/F oestrogen bound to its ER can form heterodimers
True, with different transcription factors to up or downregulate gene transcription - may be related to different types of oestrogen (less abundant forms)
Tissue specific effects of oestrogen arise due to
receptor subtypes - ER alpha and ER beta with differential affinities; multiple co-factors; can cause gene activation or repression
Rapid effects of oestrogen eg neuronal actions where oestrogens cause rapid Ca2+ influx causing rapid dilation are attributed to
in certain tissues, there are ER on the cell membrane; oestrogen may also be able to act via GPR30, a GPCR
Oestrogen binding ER generally promotes
growth and expression of the progesterone receptor PR
Progesterone receptors are upregulated by
oestrogen binding ER
Progesterone binding PR stimualtes
growth and differentiation
What is significant about ER and PR expression post menopausal?
Expression of both receptors goes up post-menopause in patients with breast cancer
Tamoxifen, Raloxifene
ER partial agonists used in tx of breast cancer; both have antagonistic effects on ER receptors in breast tissue
Fulvestrant
ER antagonist in trials for tx of breast cancer; antagonistic effects in breast, uterus, bone, CV, and CNS tissue
Tamoxifen is used as
palliative tx of metastatic breast cancer and adjuvant following lumpectomy
Tamoxifen acts as
an antagonist in breast but partial agonist in bone and endometrium
What are the adverse effects of tamoxifen?
Endometrial hyperplasia, polyps, and cancer; thromboembolic events; thrombocytopaenia; ocular toxicity; menopausal symptoms (hot flushes, atrophic vaginitis)
T/F resistance can develop to tamoxifen
True; tumours can recur because there are multiple receptors and transcription factors in the mechanism of action
Aromatase is active in
breast adipose mesenchymal cells
Why are blood oestrogen levels in post-menopausal women inaccurate?
Oestradiol may act as a paracrine hormone therefore while plasma oestrogen may be low, cellular levels will be high due to aromatase activity
Exmenostane is
an aromatase inhibitor